FDG-PET/CT for systemic staging of patients with newly diagnosed breast cancer David Groheux Editorial Commentary 01 June 2017 Pages: 1417 - 1419
18F–FDG-PET/CT for systemic staging of patients with newly diagnosed ER-positive and HER2-positive breast cancer Gary A. UlanerRaychel CastilloDebra A. Goldman Original Article 29 April 2017 Pages: 1420 - 1427
Comparison of FDG-PET/CT and contrast-enhanced CT for monitoring therapy response in patients with metastatic breast cancer Christopher C. RiedlKatja PinkerWolfgang A. Weber Original Article 01 May 2017 Pages: 1428 - 1437
Strong association of epidermal growth factor receptor status with breast cancer FDG uptake Joohee LeeEun Jeong LeeKyung-Han Lee Original Article 09 May 2017 Pages: 1438 - 1447
Overall survival and response pattern of castration-resistant metastatic prostate cancer to multiple cycles of radioligand therapy using [177Lu]Lu-PSMA-617 Hojjat AhmadzadehfarSimone WegenMarkus Essler Original Article 09 May 2017 Pages: 1448 - 1454
Comparison of PSMA-HBED and PSMA-I&T as diagnostic agents in prostate carcinoma Michael McCarthyTiffany LangtonAndrew Campbell Original Article 04 May 2017 Pages: 1455 - 1462
Diagnosis of recurrent prostate cancer with PET/CT imaging using the gastrin-releasing peptide receptor antagonist 68Ga-RM2: Preliminary results in patients with negative or inconclusive [18F]Fluoroethylcholine-PET/CT Gesche WieserIlinca PoppCordula Annette Jilg Original Article 18 April 2017 Pages: 1463 - 1472
The impact of repeated cycles of radioligand therapy using [177Lu]Lu-PSMA-617 on renal function in patients with hormone refractory metastatic prostate cancer Anna YordanovaAnja BeckerHojjat Ahmadzadehfar Original Article 23 March 2017 Pages: 1473 - 1479
Individualised 177Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry Anna SundlövKatarina Sjögreen-GleisnerJan Tennvall Original Article Open access 22 March 2017 Pages: 1480 - 1489
Personalized 177Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: a simulation study Michela Del PreteFrançois-Alexandre ButeauJean-Mathieu Beauregard Original Article 31 March 2017 Pages: 1490 - 1500
Microsurgery guided by sequential preoperative lymphography using 68Ga-NEB PET and MRI in patients with lower-limb lymphedema Xiao LongJingjing ZhangXiaoyuan Chen Original Article 05 April 2017 Pages: 1501 - 1510
Sentinel lymph node mapping using SPECT/CT and gamma probe in endometrial cancer: an analysis of parameters affecting detection rate Samine SahbaiFlorin-Andrei TaranHelmut Dittmann Original Article 03 April 2017 Pages: 1511 - 1519
Inter-heterogeneity and intra-heterogeneity of αvβ3 in non-small cell lung cancer and small cell lung cancer patients as revealed by 68Ga-RGD2 PET imaging Fei KangZhe WangJing Wang Original Article 12 April 2017 Pages: 1520 - 1528
Quantification of temporal changes in calcium score in active atherosclerotic plaque in major vessels by 18F-sodium fluoride PET/CT Yoshinobu IshiwataTomohiro KanetaTomio Inoue Original Article 27 March 2017 Pages: 1529 - 1537
Single-scan rest/stress imaging: validation in a porcine model with 18F-Flurpiridaz Nicolas J. GuehlMarc D. NormandinNathaniel M. Alpert Original Article 01 April 2017 Pages: 1538 - 1546
Long-term prognostic implications of myocardial perfusion imaging in octogenarians: an all-comer, cohort study Athanasios KatsikisAthanasios TheodorakosMaria Koutelou Original Article 08 June 2017 Pages: 1547 - 1558
Highlights lecture EANM 2016: “Embracing molecular imaging and multi-modal imaging: a smart move for nuclear medicine towards personalized medicine” Eric O. AboagyeFrançoise Kraeber-Bodéré Review Article Open access 08 June 2017 Pages: 1559 - 1574
18F-fluorodeoxyglucose positron emission tomography in the diagnosis of malignancy in patients with paraneoplastic neurological syndrome: a systematic review and meta-analysis Ana María García VicenteRoberto C. Delgado-BoltonOn behalf of the Oncology Task Force of Spanish Society of Nuclear Medicine and Molecular Imaging Review Article 27 May 2017 Pages: 1575 - 1587
Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F–DOPA Murat Fani BozkurtIrene VirgoliniStefano Fanti Guidelines 25 May 2017 Pages: 1588 - 1601
FDG PET for therapy monitoring in Hodgkin’s and non-Hodgkin’s lymphomas: qPET versus rPET Eric LaffonRoger Marthan Letter to the Editor 18 May 2017 Pages: 1602 - 1603
An insight into the EANM technologist committee benchmark document on nuclear medicine technologists’ competencies Pedro Fragoso CostaAndrea SantosGiorgio Testanera Announcements 13 June 2017 Pages: 1604 - 1606
Fibrous dysplasia mimicking bone metastasis on 68GA-PSMA PET/MRI Liesbeth De CosterRaf SciotKarolien E. Goffin Image of the Month 09 May 2017 Pages: 1607 - 1608
Diffuse 18F-FDG uptake throughout the spinal cord in the acute phase of Neuromyelitis Optica Spectrum disorder Akira HigashiyamaTsuyoshi KomoriYoshifumi Narumi Image of the Month 01 June 2017 Pages: 1609 - 1610